医学分子生物学杂志 ›› 2022, Vol. 19 ›› Issue (2): 97-104.doi: 10.3870/j.issn.1672-8009.2022.02.001

• 论著 •    下一篇

蛋白磷酸酶 4 显性负性突变体介导的活性抑制改善棕榈酸诱导 的肝细胞脂性凋亡

  

  1. 1北京师范大学生命科学学院抗性基因资源与分子发育北京市重点实验室 北京市, 100875 2北京医院国家老年医学中心, 国家卫生健康委北京老年医学研究所, 国家卫生健康委老年医学重点实验 室, 中国医学科学院老年医学研究所 北京市, 100730
  • 出版日期:2022-03-31 发布日期:2022-04-18
  • 基金资助:
    国家自然科学基金(No. 81770858,81600618)

Inhibition of Protein Phosphatase 4 Activity by Dominant Negative Mutant Ameliorates Palmitate-induced Lipoapoptosis in Hepatocytes

  1. 1Beijing Key Laboratory of Gene Resource and Molecular Development, Laboratory of Neuroscience and Brain Development, College of Life Sciences, Beijing Normal University, Beijing, 100875, China 2 The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital / National Center of Gerontology, National Health Commission, Beijing, 100730, China
  • Online:2022-03-31 Published:2022-04-18

摘要: 目的 探讨抑制蛋白磷酸酶 4 ( protein phosphatase 4, PP4) 活性对肝细胞脂性凋亡的影响。 方 法 以 400 μmol / L 的棕榈酸 (palmitic acid, PA) 处理 HepG2 细胞 24 h 建立肝细胞脂性凋亡模型; 以西方 饮食喂养 C57BL/ 6J 小鼠 16w 建立非酒精性脂肪肝炎 (non-alcoholic steatohepatitis, NASH) 模型; 构建磷酸 酶活性缺失的显性负性突变体 AD-PP4RL 腺病毒载体; 转染 AD-PP4RL 至 HepG2 细胞腺病毒以抑制肝细胞 中 PP4 的活性; 尾静脉注射 AD-PP4RL 以抑制肝脏中 PP4 的活性; 转染 RAC1 慢病毒至 HepG2 细胞中抑制 RAC1 的表达; BoDIPY 染色检测细胞及组织中脂质蓄积情况; TUNEL 染色检测细胞凋亡水平; 免疫沉淀结 合丝苏氨基酸磷酸酶活性检测法测定 PP4 活力; GTP 酶活性检测试剂盒检测 RAC1 活性; Western 印迹检测 脂质代谢及脂性凋亡相关蛋白的表达水平。 结果 ① 在 PA 处理的 HepG2 细胞及西方饮食喂养诱导的 NASH 小鼠肝脏中 PP4 活性升高; ② 过表达磷酸酶活性缺失突变的腺病毒载体 AD-PP4RL 能有效抑制 PP4 活性; ③ 抑制 PP4 活性降低 PA 诱导的 HepG2 细胞及 NASH 小鼠肝脏中脂性凋亡水平, 下调脂性凋亡相关 基因 PUMA、 Bim 及 c-caspase3 的水平; ④ RAC1 介导了在 PP4 在肝细胞脂性凋亡中的作用。 结论 抑制 PP4 活性可以通过抑制 RAC1 介导的 JNK 信号通路的激活, 改善肝细胞脂性凋亡。

关键词: 非酒精性脂肪性肝炎, 蛋白磷酸酶 4, 磷酸酶活性 PP4RL, 脂性凋亡 

Abstract: Objective To investigate the effect of protein phosphate 4 ( PP4) activation on hepatocyte lipoapoptosis. Methods HepG2 cells were treated with 400 μmol / L palmitic acid (PA) for 24 hours to establish hepatocyte lipoapoptosis model. C57BL / 6J mice were fed with Western diet for 16 weeks to establish non-alcoholic steatohepatitis (NASH) model. The PP4 dominant negative mutant adenovirus vector AD-PP4RL was constructed. HepG2 cells were transfected with AD-PP4RL adenovirus to inhibit the activity of PP4 in hepatocytes. Mice were intravenously injected through the tail vein with AD-PP4RL adenovirus to inhibit the activity of PP4 in the liver. HepG2 cells were transfected with RAC1 lentivirus to inhibit the expression of RAC1. The lipid accumulation was detected by BoDIPY staining in cells and tissues. The levels of apoptosis were detected by TUNEL staining. The activity of PP4 was determined by immunoprecipitation combined with serine-threonine phosphatase activity assay kit. The activity of RAC1 was detected by GTPase activity assay kit. The expression levels of lipid metabolism and lipid apoptosis related proteins were detected by Western blotting. Results ① The activity of PP4 was increased in HepG2 cells treated with PA and in the livers of NASH mice induced by Western diet. ② The overexpression of dominant negative mutant adenovirus vector AD-PP4RL inhibited the activity of PP4 effectively. ③ Inhibition of PP4 activity decreased the level of lipoapoptosis in PA-treated HepG2 cells and livers of NASH mice, as well as the expression levels of lipoapoptosis related genes such as PUMA, Bim and c-caspase3. ④ RAC1 mediates the role of PP4 in hepatocyte lipoapoptosis. Conclusion Inhibition of PP4 activity alleviates hepatocyte lipoapoptosis by inhibiting the RAC1-mediated JNK activation and lipoapoptosis signaling pathway. 

Key words: non-alcoholic steatohepatitis, protein phosphatase 4, dominant negative mutant PP4RL, lipoapoptosis 

中图分类号: